Technology
Health
Pharmaceutical

Urovant Sciences

$8.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-1.09%) As of 3:10 PM EDT today
-$0.09 (-1.09%) Today

Why Robinhood?

You can buy or sell UROV and other stocks, options, ETFs, and crypto commission-free!

About UROV

Urovant Sciences Ltd. Common Stock, also called Urovant Sciences, is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Read More Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.

Employees
Headquarters
London, Greater London
Founded
2016
Market Cap
256.53M
Price-Earnings Ratio
Dividend Yield
Average Volume
26.74K
High Today
$8.87
Low Today
$7.99
Open Price
$8.54
Volume
14.20K
52 Week High
$14.49
52 Week Low
$4.06

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2018 IPO
UK
Europe

UROV Earnings

-$1.23
-$1.08
-$0.92
-$0.77
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Aug 12, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.